0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Invited Commentary  | 
Improved Outcomes in Metastatic Colon Cancer:  Giving Credit Where Credit Is Due
Daniel Sargent, PhD
JAMA Oncology
Original Investigation  | 
Colorectal Cancer Survival Gains and Novel Treatment Regimens:  A Systematic Review and Analysis
Irfan Jawed, MD; Julia Wilkerson, MSc; Vinay Prasad, MD, MPH; et al.
JAMA Surgery
Invited Commentary  | 
Elevation of Pretreatment Carcinoembryonic Antigen Level as a Prognostic Factor for Colon Cancer:  Incorporating a C Stage in the AJCC TNM Classification
Ramzi Amri, MD; David L. Berger, MD
JAMA Surgery
Original Investigation  | 
Effect of Incorporation of Pretreatment Serum Carcinoembryonic Antigen Levels Into AJCC Staging for Colon Cancer on 5-Year Survival
Pragatheeshwar Thirunavukarasu, MD; Chetasi Talati, MD; Sumeet Munjal, MD; et al.